We are the region’s largest group of cancer specialists, bringing the world’s best new treatments to our patients right here.

At Green Bay Oncology, there is strength in numbers. With the area’s largest cancer-fighting team, our patients are assured that they are not the sole responsibility of one doctor. We have many medical oncology, hematology, and radiation experts who collaborate every day on every case, supported with a full team of expert advanced practitioners. This depth of attention and care leads to a better chance of success for our patients. Learn more about our oncologists, about us, or find a convenient cancer treatment location near you.

 

In Partnership with National Cancer Institute

The National Cancer Institute has designated Green Bay Oncology as the region’s longest participant in its renowned Community Oncology Research Program (NCORP):

  • One of just 34 NCORPs in the U.S. and one of only two in Wisconsin.
  • Conducting clinical trials to evaluate new cancer treatment options.
  • Identifying new ways to detect, diagnose and treat cancer.

This means our patients get access to groundbreaking new treatments, often years before anyone else.

  • Recent Posts:

    Dr. Jules Blank actually treated my mother when she had leukemia. She passed away very young and I was just 12 years old at the time. I never would have imagined that I would come full circle and be receiving a scholarship in Dr. Blank’s name to continue my education in healthcare. They didn’t know… Continue reading

    Dr. Jules Blank actually treated my mother when she had leukemia. She passed away very young and I was just 12 years old at the time. I would never have imagined that I would come full circle and be receiving a scholarship in Dr. Blank’s name to continue my education in healthcare. They didn’t know… Continue reading
  • Spotlight:

    Getting the most advanced cancer treatment to patients requires that cancer doctors do two things:  support the process that develops these treatments, and give their patients access to these trial-phase treatments. However, only one in five U.S. oncologists participates in the NCORP – the National Cancer Institute’s pipeline that delivers clinical trials from the academic centers to
  • Upcoming Events: